| |
|
2015³â 10¿ù 23ÀÏ (±Ý)
|
|
ÀÌ°ú
|
|
ÁßÀÌ ±âÃÊ
|
08:00~08:50 |
Chairperson(s) : ±è¿µÈ£,¹Ú½Ã³» |
|
OTOP-06 08:00~08:10 |
Differential protein expression in congenital and acquired cholesteatomas...
....................ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç©ö, ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç©÷ ........½Å½ÂÈ£©ö,±è¼ºÇå©÷, ÃÖÀ翵©÷ |
|
OTOP-07 08:10~08:20 |
Osteogenic effect of BMP coated PCL nano scaffold...
....................°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç ........¼ÛÀçÁØ, ±èÈñº¹, °íÀ±¿µ, 伺¿ø |
|
OTOP-08 08:20~08:30 |
Antifibrotic effect of dexamethasone/alginate coated silastic sheet in the middle ear ...
....................Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç©ö, ¼º±Õ°ü´ëÇб³ »ý¸í°øÇаú Biomechatronics©÷ ........Àåöȣ©ö, Á¶¿ë¹ü©ö, ¾È½ÂÇö©÷,±è±ÙÇü©÷©ö |
|
OTOP-09 08:30~08:40 |
The role of group 3 innate lymphoid cells in otitis media rat model...
....................µ¿±¹´ë Àϻ꺴¿ø ........°ø¼ºÈ£, ¹ÚÁÖÇö, ÀÓÀ±¼º, ¹Ú¼®¿ø, Á¶Ã¢°Ç |
|
OTOP-10 08:40~08:50 |
Äɶóƾ À¯¹ß °ñÆı« ¸¶¿ì½º ¸ðµ¨°ú periostinÀÇ ¿ªÇÒ...
....................°æ»ó´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø À̺ñÀÎÈÄ°úÇб³½Ç ........Ç㵿±¸, ±èÁø¿ë, ¾È¼º±â |
|
|
|
|
|
|